Search details
1.
Changes in metabolic risk, insulin resistance, leptin and adiponectin following a lifestyle intervention in overweight and obese breast cancer survivors.
Eur J Cancer Care (Engl)
; 27(4): e12861, 2018 Jul.
Article
in English
| MEDLINE | ID: mdl-29869823
2.
Translational Research Opportunities Regarding Homologous Recombination in Ovarian Cancer.
Int J Mol Sci
; 19(10)2018 Oct 19.
Article
in English
| MEDLINE | ID: mdl-30347758
3.
High Proliferation Predicts Pathological Complete Response to Neoadjuvant Chemotherapy in Early Breast Cancer.
Oncologist
; 21(2): 150-5, 2016 Feb.
Article
in English
| MEDLINE | ID: mdl-26786263
4.
Elderly patients with hormone receptor-positive HER2-negative metastatic breast cancer treated with CDK4/6 inhibitors in a multicentre cohort.
Clin Transl Oncol
; 2024 Mar 22.
Article
in English
| MEDLINE | ID: mdl-38519708
5.
SAMHD1 expression is a surrogate marker of immune infiltration and determines prognosis after neoadjuvant chemotherapy in early breast cancer.
Cell Oncol (Dordr)
; 47(1): 189-208, 2024 Feb.
Article
in English
| MEDLINE | ID: mdl-37667113
6.
SEOM-GEICAM-SOLTI clinical guidelines in advanced breast cancer (2022).
Clin Transl Oncol
; 25(9): 2665-2678, 2023 Sep.
Article
in English
| MEDLINE | ID: mdl-37148499
7.
SAMHD1 expression modulates innate immune activation and correlates with ovarian cancer prognosis.
Front Immunol
; 14: 1112761, 2023.
Article
in English
| MEDLINE | ID: mdl-36845138
8.
Pre- and Post-Neoadjuvant Clinicopathological Parameters Can Help in the Prognosis and the Prediction of Response in HER2+ and Triple Negative Breast Cancer.
Cancers (Basel)
; 15(12)2023 Jun 06.
Article
in English
| MEDLINE | ID: mdl-37370679
9.
Circulating tumor DNA reveals complex biological features with clinical relevance in metastatic breast cancer.
Nat Commun
; 14(1): 1157, 2023 03 01.
Article
in English
| MEDLINE | ID: mdl-36859416
10.
HOPE (SOLTI-1903) breast cancer study: real-world, patient-centric, clinical practice study to assess the impact of genomic data on next treatment decision-choice in patients with locally advanced or metastatic breast cancer.
Front Oncol
; 13: 1151496, 2023.
Article
in English
| MEDLINE | ID: mdl-37188177
11.
Role of ctDNA in Breast Cancer.
Cancers (Basel)
; 14(2)2022 Jan 09.
Article
in English
| MEDLINE | ID: mdl-35053474
12.
Targeted Therapeutic Options and Future Perspectives for HER2-Positive Breast Cancer.
Cancers (Basel)
; 14(14)2022 Jul 06.
Article
in English
| MEDLINE | ID: mdl-35884366
13.
Efficacy of CT-P6 (trastuzumab biosimilar) versus reference trastuzumab in combination with pertuzumab in HER2-positive early-stage breast cancer: Preclinical and real-life clinical data.
Breast
; 62: 1-9, 2022 Apr.
Article
in English
| MEDLINE | ID: mdl-35078146
14.
Conventional and digital Ki67 evaluation and their correlation with molecular prognosis and morphological parameters in luminal breast cancer.
Sci Rep
; 12(1): 8176, 2022 05 17.
Article
in English
| MEDLINE | ID: mdl-35581229
15.
Modulation of DNA Damage Response by SAM and HD Domain Containing Deoxynucleoside Triphosphate Triphosphohydrolase (SAMHD1) Determines Prognosis and Treatment Efficacy in Different Solid Tumor Types.
Cancers (Basel)
; 14(3)2022 Jan 27.
Article
in English
| MEDLINE | ID: mdl-35158911
16.
Overall survival with palbociclib plus endocrine therapy versus capecitabine in postmenopausal patients with hormone receptor-positive, HER2-negative metastatic breast cancer in the PEARL study.
Eur J Cancer
; 168: 12-24, 2022 06.
Article
in English
| MEDLINE | ID: mdl-35429901
17.
High Proliferation Predicts Pathological Complete Response to Neoadjuvant Chemotherapy in Early Breast Cancer.
Oncologist
; 21(6): 778, 2016 06.
Article
in English
| MEDLINE | ID: mdl-27317735
18.
Prognostic value of hematogenous dissemination and biological profile of the tumor in early breast cancer patients: a prospective observational study.
BMC Cancer
; 11: 252, 2011 Jun 16.
Article
in English
| MEDLINE | ID: mdl-21679400
19.
Cyclin-dependent Kinases as Emerging Targets for Developing Novel Antiviral Therapeutics.
Trends Microbiol
; 29(9): 836-848, 2021 09.
Article
in English
| MEDLINE | ID: mdl-33618979
20.
Health-related quality of life with palbociclib plus endocrine therapy versus capecitabine in postmenopausal patients with hormone receptor-positive metastatic breast cancer: Patient-reported outcomes in the PEARL study.
Eur J Cancer
; 156: 70-82, 2021 10.
Article
in English
| MEDLINE | ID: mdl-34425406